The SLC5A1 gene helps the small intestine absorb the sugars glucose and galactose from food, and it also helps the kidneys reclaim glucose from urine. This gene plays an important role in moving these sugars into the body with sodium; if the SLC5A1 gene does not work properly, sugars stay in the gut and draw in water. People with two nonworking variants can develop glucose-galactose malabsorption, which often causes watery diarrhea, dehydration, and poor weight gain soon after feeding begins.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or direct activities in the body. Some genes hold the information needed to produce proteins, the functional parts of cells. Other genes mainly regulate when certain processes happen, where they happen, and how strongly they occur. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medicines. To explore this topic further, you can find more in the LearnHub.
Overview
SLC5A1Gene function
What if the gene works
The SLC5A1 gene helps the small intestine absorb glucose and galactose from food. It also supports reabsorption of these sugars in the kidneys, helping your body use energy and limit sugar loss in urine.
Risk
What if the gene does not work
More severe variants in the SLC5A1 gene can cause glucose-galactose malabsorption, often beginning in infancy with watery diarrhea, dehydration, and poor weight gain. Milder variants may leave some sugar transport working, which can affect symptom timing and severity.
Treatment
What does that mean for your treatment
Pathogenic variants in the SLC5A1 gene mean treatment relies on removing glucose and galactose from the diet, especially in infancy. Fructose-based formulas and foods are usually used instead because fructose is absorbed through a different route. Standard glucose-containing oral rehydration solutions may not work well, so hydration plans are adjusted accordingly.
Conditions associated with SLC5A1
Gene function
What if the gene works
After a meal, your gut needs a reliable way to pull sugar from food into the body. The SLC5A1 gene helps make a transport protein that moves glucose and galactose across the lining of the small intestine. It also supports sugar recovery in the kidneys, so useful fuel is not lost in urine.
The SLC5A1 gene helps cells in the small intestine take in glucose and galactose from digested food. It uses sodium moving into the cell at the same time, which allows sugar absorption from food to happen efficiently.
In the kidneys, this gene helps reclaim glucose from the forming urine back into the body. That supports day to day energy balance and helps conserve a useful fuel source.
Its transport protein moves sodium and sugar together across the cell surface. This lets the body use a sodium gradient (a difference in sodium levels) to drive sugar transport.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC5A1 gene can misshape, shorten, or destabilize its transport protein, or keep it from reaching the cell surface, so glucose and galactose move poorly or not at all. Some SLC5A1 gene variants leave partial transport activity, while more severe variants can nearly abolish it. This range in functional impact helps explain why glucose-galactose malabsorption may start earlier and be more pronounced in some people than in others.
How variants are linked to conditions
Pathogenic variants in the SLC5A1 gene are best known for causing glucose-galactose malabsorption, a rare inherited condition that usually starts in newborns with severe watery diarrhea and dehydration after milk or formula feeds. A diagnosis of SLC5A1-related glucose-galactose malabsorption is typically confirmed when a person inherits a pathogenic variant from each parent.
A variant is not necessarily a diagnosis
Genetic variants are a common and normal part of human biology. Most of them do not directly affect health and simply reflect natural variation among people. For many genes, carrying a variant associated with a condition suggests a possible link rather than a clear diagnosis, especially when more than one gene and environmental factors contribute. In some instances, though, a single well characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SLC5A1, the main factor is inheritance: a child is affected when they receive a nonworking copy of the gene from both parents, so family history can change the chance. For someone who already has this condition, foods and drinks with glucose or galactose can trigger symptoms, but they do not change the underlying genetic cause.
Inheritance of SLC5A1 variants
SLC5A1-related glucose-galactose malabsorption follows an autosomal recessive inheritance pattern. This means a child usually inherits one SLC5A1 gene variant from each parent, and parents who carry one variant typically do not have the condition themselves. When both parents are carriers, each pregnancy has a 25% chance of an affected child, a 50% chance of a child who is a carrier, and a 25% chance of a child with no inherited variant. The SLC5A1 inheritance pattern affects boys and girls equally.
What does my SLC5A1 result mean for my family?
For families with an SLC5A1-related condition, close relatives may also carry the same gene change. Parents are often healthy carriers, and brothers or sisters may also be affected or be carriers even if they seem well. Other relatives on both sides of the family may carry the change too, so the result can matter beyond one person.
Genetic information
Genetic testing
How you find out about variants
SLC5A1 genetic testing looks for variants in the SLC5A1 gene using a blood or saliva sample. A lab reads the gene’s DNA sequence and checks for changes that may explain symptoms such as severe diarrhea in infancy or confirm glucose-galactose malabsorption. Results can show whether a variant is present, absent, or uncertain.
When should I consider getting a genetic test?
Genetic testing for the SLC5A1 gene may be worth considering when a baby has severe watery diarrhea and dehydration soon after starting breast milk or formula, especially if symptoms improve when glucose and galactose are removed from the diet. It can also help if this condition runs in the family.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains depends on the condition and on the kind of variant involved. Lifestyle, environment, age, and medical history are among the many factors that influence how the body functions over time. In some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best considered together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, transports, or reacts to a drug, so the same treatment may work better for one person than for another. This is common and can influence both how well a medicine helps and how likely someone is to notice side effects.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that examines how genetic differences affect the way people respond to medications. It focuses on links between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence either how strongly a drug works or how the body processes it. This information can support more informed and more individualized treatment decisions. To explore this topic in greater detail, you can learn more in the LearnHub.
Drugs influenced by the SLC5A1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work. If you have concerns about side effects, new symptoms after starting a treatment, or whether a medicine is helping, talk with your doctor.
History
SLC5A1 entered medical research through studies of children with a rare inherited condition later called glucose-galactose malabsorption. Initially understood only through visible traits, later recognized as tied to a specific gene, this work helped connect severe infant diarrhea with a specific inherited cause. In the late 1980s and early 1990s, researchers identified and cloned the SLC5A1 gene, linking it to the sodium glucose cotransporter known as SGLT1. From these first observations, research expanded steadily. The gene also became important in basic physiology because it helped confirm how the small intestine absorbs sugars. Over time, SLC5A1 moved from a rare disease clue to a well-established part of genetics and digestive medicine.